Charles Schwab’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57K Sell
42,188
-30,638
-42% -$61.6K ﹤0.01% 3415
2025
Q4
$189K Hold
72,826
﹤0.01% 3351
2025
Q3
$218K Sell
72,826
-10,513
-13% -$37.5K ﹤0.01% 3341
2025
Q2
$335K Buy
83,339
+7,601
+10% +$28K ﹤0.01% 3280
2025
Q1
$252K Hold
75,738
﹤0.01% 3232
2024
Q4
$468K Buy
75,738
+5,215
+7% +$30.3K ﹤0.01% 3158
2024
Q3
$394K Hold
70,523
﹤0.01% 3218
2024
Q2
$527K Buy
70,523
+31,407
+80% +$194K ﹤0.01% 3174
2024
Q1
$227K Hold
39,116
﹤0.01% 3221
2023
Q4
$193K Hold
39,116
﹤0.01% 3279
2023
Q3
$200K Hold
39,116
﹤0.01% 3291
2023
Q2
$264K Buy
+39,116
New +$232K ﹤0.01% 3259

Other funds holding BTMD

Charles Schwab's BTMD Position: Q1 2026 in Review

Charles Schwab reduced its Biote Corp (BTMD) stake by 42% in Q1 2026, selling an estimated $61.6K and leaving 42,188 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #3415.

Charles Schwab first reported a position in BTMD in Q2 2023 and has held it in 12 quarters since. The position peaked at $527K in Q2 2024. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • Charles Schwab held 42,188 shares of Biote Corp worth $57K as of Q1 2026.
  • Charles Schwab sold 30,638 Biote Corp shares in Q1 2026, an estimated $61.6K.
  • Biote Corp made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #3415 holding.
  • Charles Schwab first reported a position in Biote Corp in Q2 2023 and has held it in 12 quarters since.
  • Charles Schwab's Biote Corp position peaked at $527K in Q2 2024.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.